Clinical Trial Update: Compliance: Role Emerges for Success in Chronic Myelogenous Leukaemia (CML): Evaluation aND Optimisation [Phase 4]

View source ↗

Summary

Phase 4 trial update on Chronic Myelogenous Leukemia (CML) evaluating compliance and optimization strategies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | Conditions: Chronic Myelogenous Leukemia (CML) | Phase 4 | Status: COMPLETED